- Aguilera G., Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation 2000; 96: 23-29
- Andres M., Trueba M., Guillon G. Pharmacological characterization of F-180: a selective human V1a vasopressin receptor agonist of high affinity 2002; 135: 1828-1836
- Barberis C., Morin D., Durroux T., Mouillac B., Guillon G., Seyer R., Hibert M., Tribollet E., Manning M. Molecular pharmacology of AVP and OT receptors and therapeutic potential 1999; 12: 279-292
- Ben Mimoun M., Derick S., Andres M., Guillon G., Wo N.C., Chan W.Y., Stoev S., Cheng L.L., Manning M., Martinez J., Fehrentz J.A. Affinities for rat V2 and V1a receptors reveal surprising species differences 2001; 589-590Editions Medicales et Scientifiques
- Derick S., Cheng L., Voirol M.J., Stoev S., Giacomini M., Wo N.C., Szeto H.H., Ben Mimoun M., Andres M., Gaillard R.C., Guillon G., Manning M. [1-Deamino-4-Cyclohexylalanine] arginine vasopressin: A potent and specific agonist for vasopressin V1b receptors 2002; 143: 4655-4664
- De Wied D. The influence of the posterior and intermediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response in rats 1965; 4: 157-167
- Dreifuss J.J., Tribollet E., Goumaz M., Dubois-Dauphin M., Raggenbass M., Jard S., Jamison R. Vasopressin receptor localization and neuronal responsiveness in the rat brain 1991; 159-166John Libbey Eurotext
- Gillies G.E., Linton E.A., Lowry P.J. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin 1982; 299: 355-357
- Grazzini E., Lodboerer A.M., Perez-Martin A., Joubert D., Guillon G. Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla 1996; 137: 3906-3939
- Griebel G., Simiand J., Serradeil-Le Gal C., Wagnon J., Pascal M., Scatton B., Maffrand J.P., Soubrie P. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders 2002; 99: 6370-63759
- Hernando F., Schoots O.J., Lolait S.H., Burbach J.P. Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: Anatomical support for its involvement in the central effects of vasopressin 2001; 1420: 1659-1668
- Holsboer F. The rationale for corticotropin-releasing hormone receptor (CHR-R) antagonists to treat depression and anxiety 1999; 33: 181-214
- Jard S., Zingg H.H., Bourque C.W., Bichet D.G. 1998; 449: 1-13Plenum Press
- Jard S., Gaillard R.C., Guillon G., Marie J., Schoenenberg P., Muller A.F., Manning M., Sawyer W.H. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis 1986; 30: 171-177
- Kruszynski M., Lammek B., Manning M., Seto J., Haldar J., Sawyer W.H. [1-(beta-mercapto-beta-cyclopentamethylenepropionic acid)2-( O -methyl) tyrosine] arginine-vasopressin and [1-(beta-mercapto-beta, beta-cyclopentamethylenepropionic acid)] arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin 1980; 23: 364-368
- Lee B., Yang C., Chen T.H., Aal-Azawi N. Effect of AVP and oxytocin on insuline release: involvement of V1b receptors 1995; 269: E1095-E1100 et al.
- Liebsch G., Wotjak C.T., Landgraf R., Engelmann M. Septal vasopressin modulates anxiety-related behavior in rats 1996; 217: 101-104
- Lolait S.J., O'Carroll A.M., Brownstein M.J. Molecular biology of vasopressin receptors 1995; 771: 273-292
- Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments 1977; 266: 730-732
- Raadsheer F.C., Hoogendijk W.J., Stam F.C., Tilders F.J., Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients 1994; 60: 436-444
- Rabadan-Diehl C., Lolait S.J., Aguilera G. Regulation of pituitary vasopressin V1b receptor mRNA during stress in the rat 1995; 7: 903-910
- Ramachandran J. Corticotropin receptors, cyclic AMP and steroidogenesis 1984-1985; 10: 347-363
- Saito M., Tahara A., Sugimoto T., Abe K., Furuichi K. Evidence that atypical vasopressin V2 receptor in inner medulla of kidney is V1b receptor 2002; 401: 289-296
- Schwartz J., Derdowska I., Sobocinska M., Kupryszewski G. A potent new synthetic analog of vasopressin with relative agonist specificity for the pituitary 1991; 129: 1107-1109
- Serradeil-Le Gal C., Wagnon J., Garcia G., Lacour C., Barthelemy P., Guiraudou D., Nisato G., Le Fur G., Maffrand J.P., Cantau B., Barberis C., Guillon G., Jard S. Biological and pharmacological properties of SR 49059, a new potent, nonpeptide antagonist of rat and human vasopressin V1a receptors 1993; 92: 224-231
- Serradeil-Le Gal C., Lacour C., Valette G., Garcia G., Foulon L., Galindo G., Bankir L., Pouzet B., Guillon G., Barberis C., Chicot D., Jard S., Vilain P., Garcia C., Marty E., Raufaste D., Brossard G., Nizato D., Maffrand J.P., Le Fur G. Characterization of SR 121463A, A highly potent and selective, orally-active vasopressinvéreceptor antagonist 1996; 98: 2729-2738
- Serradeil-Le-Gal C., Wagnon J., Simiand J., Griebel G., Lacour C., Guillon G., Barberis C., Brossard G., Soubrie P., Nisato D., Pascal M., Pruss R., Scatton B., Maffrand J.-P., Le Fur G. Characterization of (2S, 4R)-1-[5-chloro-1-[(2, 4-dimethoxyphenyl) sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-zyl]4-hydroxy- N N -dimethyl-2-pyrrolidine carboxamide (SSR 149415), a selective and orally active vasopressine V1b receptor antagonist 2002; 300: 1122-1130
- Thibonnier M., Preston J.A., Dulin N., Wilkins P.L., Berti-Mattera L.N., Mattera R. The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways 1997; 138: 4109-4122
- Vaccari C., Lolait S.J., Ostrowski N.L. Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain 1998; 139: 5015-5033
- Vogel J.R., Beer B., Clody D.E. Chronic mild stress-induced anhedonia: a realisti model of depression 1971; 21: 1-7
- Wersinger S.R., Ginns E.I., O'Carrol A.-M., Lolait S.J., Young III W.S. VasopressinV1b receptor knockout reduces aggressive behavior in male mice 2002; 7: 975-984
- Willner P., Muscat R., Papp M. 1992; 16: 525-534
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research